Renal replacement therapy in special settings: Extracorporeal support devices in liver failure

Seminars in Dialysis

Volumn 24, Issue 2, 2011, Pages 197-202

  Cerdá, Jorge ^a   Tolwani, Ashita ^b   Gibney, Noel ^c   Tiranathanagul, Khajohn ^d  

^a ALBANY MEDICAL COLLEGE   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL LIVER; ARTIFICIAL MEMBRANE; CELL FREE SYSTEM; DETOXIFICATION; FLUID THERAPY; HEMOPERFUSION; HEPATORENAL SYNDROME; HUMAN; LIVER TRANSPLANTATION; METHODOLOGY; PLASMAPHERESIS; RENAL REPLACEMENT THERAPY; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

CELL-FREE SYSTEM; FLUID THERAPY; HEMOPERFUSION; HEPATORENAL SYNDROME; HUMANS; LIVER TRANSPLANTATION; LIVER, ARTIFICIAL; MEMBRANES, ARTIFICIAL; PLASMAPHERESIS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RENAL REPLACEMENT THERAPY; SORPTION DETOXIFICATION;

EID: 79955108236     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2011.00827.x     Document Type: Article

References (69)

1. Gines A, Escorsell A, Gines P, Salo J, Jimenez W, Inglada L, Navasa M, Claria J, Rimola A, Arroyo V: Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 105(1):229-236, 1993
2. Gines P, Guevara M, Arroyo V, Rodes J: Hepatorenal syndrome. Lancet 362(9398):1819-1827, 2003
3. Gonwa TA, Mai ML, Melton LB, Hays AS, Goldstein RM, Levy MF, Kintmalm GB: Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome-experience in 300 patients. Transplantation 51(2):428-430, 1991
4. Jeyarajah DR, Gonwa TA, McBride M, Testa G, Abbasoglu O, Husberg BS, Levy MF, Goldstein RM, Klintmalm GB: Hepatorenal syndrome: combined liver kidney transplants versus isolated liver transplant. Transplantation 64(12):1760-1765, 1997
5. Gonwa TA, Poplawski S, Paulsen W, Brajtbord D, Goldstein R, Husberg B, Kintmalm GB: Pathogenesis and outcome of hepatorenal syndrome in patients undergoing orthotopic liver transplant. Transplantation 47(2):395-397, 1989
6. Kellum JA, Bellomo R, Ronco C: Acute dialysis quality initiative (ADQI): methodology. Int J Artif Organs 31:90-93, 2008
7. Witzke O, Baumann M, Patschan D, Patshcan S, Mitchell A, Treichel U, Gerken G, Philipp T, Kribben A: Which patients benefit from hemodialysis therapy in hepatorenal syndrome? J Gastroenterol Hepatol 19:1369-1373, 2004
8. Chang TM: Haemoperfusions over microencapsulated adsorbent in a patient with hepatic coma. Lancet 2(7791):1371-1372, 1972
9. Gazzard BG, Langley PG, Weston MJ, Dunlop EH, Williams R: Polymer coating of activated charcoal and its effects on biocompatibility and paracetamol binding. Clin Sci Mol Med 47(2):97-104, 1974
10. Gimson AE, Braude S, Mellon PJ, Canalese J, Williams R: Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet 2(8300):681-683, 1982
11. Splendiani G, Tancredi M, Daniele M, Giammaria U: Treatment of acute liver failure with hemodetoxification techniques. Int J Artif Organs 13(6):370-374, 1990
12. Bihari D, Hughes RD, Gimson AE, Langley PG, Ede RJ, Eder G, Williams R: Effects of serial resin hemoperfusion in fulminant hepatic failure. Int J Artif Organs 6(6):299-302, 1983
13. O'Grady JG, Gimson AE, O'Brien CJ, Pucknell A, Hughes RD, Williams R: Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 94:1186-1192, 1988
14. Ash SR, Blake DE, Carr DJ, Carter C, Howard T, Makowka L: Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma (the BioLogic-DT). Int J Artif Organs 15(3):151-161, 1992
15. Hughes RD, Pucknell A, Routley D, Langley PG, Wendon JA, Williams R: Evaluation of the BioLogic-DT sorbent-suspension dialyser in patients with fulminant hepatic failure. Int J Artif Organs 17(12):657-662, 1994
16. Ellis AJ, Hughes RD, Nicholl D, Langley PG, Wendon JA, O'Grady JG, et al.: Temporary extracorporeal liver support for severe acute alcoholic hepatitis using the BioLogic-DT. Int J Artif Organs 22(1):27-34, 1999
17. Wilkinson AH, Ash SR, Nissenson AR: Hemodiabsorption in treatment of hepatic failure. J Transpl Coord 8:43-50, 1998
18. Lepore MJ, Martel AJ: Plasmapheresis in hepatic coma. Lancet 2:771-772, 1967
19. Lepore MJ, Stutman LJ, Bonanno CA, Conklin EF, Robilotti JG Jr, McKenna PJ: Plasmapheresis with plasma exchange in hepatic coma. II Fulminant viral hepatitis as a systemic disease. Arch Intern Med 129(6): 900-907, 1972
20. Matsubara S, Okabe K, Ouchi K, Sato T, Matsuno S: Temporary metabolic support by extracorporeal blood therapy for liver failure after surgery. ASAIO Trans 34(3):266-269, 1988
21. Yoshiba M, Sekiyama K, Iwamura Y, Sugata F: Development of reliable artificial liver support (ALS)-plasma exchange in combination with hemodiafiltration using high-performance membranes. Dig Dis Sci 38(3):469-476, 1993
22. Kondrup J, Almdal T, Vilstrup H, Tygstrup N: High volume plasma exchange in fulminant hepatic failure. Int J Artif Organs 15(11):669-676, 1992
23. Larsen FS, Hansen BA, Jorgensen LG, Secher NH, Kirkegaard P, Tygstrup N: High-volume plasmapheresis and acute liver transplantation in fulminant hepatic failure. Transpl Proc 26(3):1788, 1994
24. Larsen FS, Hansen BA, Ejlersen E, Secher NH, Clemmesen JO, Tygstrup N, Knudsen GM: Cerebral blood flow, oxygen metabolism and transcranial Doppler sonography during high-volume plasmapheresis in fulminant hepatic failure. Eur J Gastroenterol Hepatol 8(3):261-265, 1996
25. Clemmesen JO, Gerbes AL, Gulberg V, Hansen BA, Larsen FS, Skak C, Tygstrup N, Ott P: Hepatic blood flow and splanchnic oxygen consumption in patients with liver failure. Effect of high-volume plasmapheresis. Hepatology 29(2):347-355, 1999
26. Morimoto T, Matsushima M, Sowa N, Ide K, Sawanishi K: Plasma adsorption using bilirubin-adsorbent materials as a treatment for patients with hepatic failure. Artif Organs 13(5):447-452, 1989
27. Senf R, Klingel R, Kurz S, Tullius S, Sauer I, Frei U, Schindler R: Bilirubin-adsorption in 23 critically ill patients with liver failure. Int J Artif Organs 27(8):717-722, 2004
28. Geiger H, Klepper J, Lux P, Heidland A: Biochemical assessment and clinical evaluation of a bilirubin adsorbent column (BR-350) in critically ill patients with intractable jaundice. Int J Artif Organs 15(1):35-39, 1992
29. Ott R, Rupprecht H, Born G, Muller V, Reck T, Hohenberger W, Kockerling F: Plasma separation and bilirubin adsorption after complicated liver transplantation: a therapeutic approach to excessive hyperbilirubinemia. Transplantation 65(3):434-437, 1998
30. Tabei K, Akai Y, Takeda S, Homma S, Kusano E, Asano Y: Application of plasma perfusion in hepatic failure. Biomater Artif Cells Immobilization Biotechnol 19(1):193-201, 1991
31. Usami M, Nomura H, Nishimatsu S, Shiroiwa H, Kasahara H, Takeyama Y, Saitoh Y: In vivo and in vitro evaluation of bilirubin removal in postoperative hyperbilirubinemia patients. Artif Organs 19(1):102-105, 1995
32. Li LJ, Yang Q, Huang JR, Xu XW, Chen YM, Fu SZ: Effect of artificial liver support system on patients with severe viral hepatitis: a study of four hundred cases. World J Gastroenterol 10(20):2984-2988, 2004
33. Rozga J, Umehara Y, Trofimenko A, Sadahiro T, Demetriou AA: A novel plasma filtration therapy for hepatic failure: preclinical studies. Ther Apher Dial 10:138-144, 2006
34. Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, Berger ED, Lauchart W, Peszynski P, Freytag J, Hickstein H, Loock J, Löhr JM, Liebe S, Emmrich J, Korten G, Schmidt R: Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 6:277-286, 2000
35. Khuroo MS, Khuroo MS, Farahat KL: Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis. Liver Transpl 10:1099-1106, 2004
36. Wong F, Raina N, Richardson R: Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in cirrhotic patients with ascites who have failed vasoconstrictor therapy. Gut 5:381-386, 2010
37. Camus C, Lavoué S, Gacouin A, Compagnon P, Boudjéma K, Jacquelinet C, Thomas R, Le Tulzo Y: Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent recirculating system while on the waiting list: impact of the duration of therapy. Ther Apher Dial 13:549-555, 2009
38. Hassanein TI, Tofteng F, Brown Jr RS, McGuire B, Lynch P, Mehta R, Larsen FS, Gornbein J, Stange J, Blei AT: Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 46(6):1853-1862, 2007
39. Li LJ, Zhang YM, Liu XL, Du WB, Huang JR, Yang Q, Xu XW, Chen YM: Artificial liver support system in China: a review over the last 30years. Ther Apher Dial 10:160-167, 2006
40. Vienken J, Christmann H: How can liver toxins be removed? Filtration and adsorption with the Prometheus system. Ther Apher Dial 10:125-131, 2006
41. Grodzicki M, Kotulski M, Leonowicz D, Zieniewicz K, Krawczyk M: Results of treatment of acute liver failure patients with use of the prometheus FPSA system. Transplant Proc 41:3079-3081, 2009
42. Rifai K, Ernst T, Kretschmer U, Bahr MJ, Schneider A, Hafer C, Haller H, Manns MP, Fliser D: The prometheus device for extracorporeal support of combined liver and renal failure. Blood Purif 23:298-302, 2005
43. Boonsrirat U, Tiranathanagul K, Srisawat N, Susantitaphong P, Komolmit P, Praditpornsilpa K, Tungsanga K, Eiam-Ong S: Effective bilirubin reduction by single-pass albumin dialysis in liver failure. Artif Organs 33:648-653, 2009
44. Rahman E, Al Suwaida AK, Askar A: Single pass albumin dialysis in hepatorenal syndrome. Saudi J Kidney Dis Transpl 19:479-484, 2008
45. Karvellas CJ, Bagshaw SM, McDermid RC, Stollery DE, Bain VG, Gibney RT: A case-control study of single-pass albumin dialysis for acetaminophen-induced acute liver failure. Blood Purif 28:151-158, 2009
46. Sauer IM, Goetz M, Steffen I, Walter G, Kehr DC, Schwartlander R, Hwang YJ, Pascher A, Gerlach JC, Neuhaus P: In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD). Hepatology 39:1408-1414, 2004
47. Seabra VF, Balk EM, Liangos O, Sosa MA, Cendoroglo M, Jaber BL: Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis. Am J Kidney Dis 52(2):272-284, 2008
48. Gettings LG, Reynolds HN, Scalea T: Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early vs late. Intensive Care Med 25(8):805-813, 1999
49. Wu VC, Ko WJ, Chang HW, Chen YS, Chen YW, Hu FC, Lin YH, Tsai PR, Wu KD: Early renal replacement therapy in patients with postoperative acute liver failure associated with acute renal failure: effect on postoperative outcomes. J Am Coll Surg 205(2):266-276, 2007
50. Liu KD, Himmelfarb J, Paganini E, Ikizler TA, Soroko SH, Mehta RL, Chertow GM: Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol 1(5):915-919, 2006
51. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J: Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 30(10):2205-2211, 2002
52. Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P; for the VA/NIH Acute Renal Failure Trial Network: Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359: 7-20, 2008
53. RENAL Replacement Therapy Study Investigators; Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S: Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361:1627-1638, 2009
54. Davenport A, Bouman C, Kirpalani A, Skippen P, Tolwani A, Mehta RL, Palevsky PM: Delivery of renal replacement therapy in acute kidney injury: what are the key issues? Clin J Am Soc Nephrol 3:869-875, 2008
55. Kellum JA, Angus DC, Johnson JP, Leblanc M, Griffin M, Ramakrishnan N, Linde-Zwirble WT: Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 28:29-37, 2002
56. Tonelli M, Manns B, Feller-Kopman D: Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 40:875-885, 2002
57. Davenport A, Will EJ, Davison AM, Swindells S, Cohen AT, Moloszewski KJ, Losowsky MS: Changes in intracranial pressure during haemofiltration in oliguric patients with grade IV hepatic encephalopathy. Nephron 53:142-146, 1989
58. Davenport A, Will EJ, Davison AM: Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure. Kidney Int Suppl 41:S245-S251, 1993
59. Ward DM: The approach to anticoagulation in patients treated with extracorporeal therapy in the intensive care unit. Adv Ren Replace Ther 4: 160-173, 1997
60. Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T: Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 29:748-752, 2001
61. Brophy P, Somers M, Baum M, Symons J, McAfee N, Fortenberry JD, Rogers K, Barnett J, Blowey D, Baker C, Bunchman TE, Goldstein SL: Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol Dial Transplant 20:1416-1421, 2005
62. Rifai K, Ernst T, Kretschmer U, Bahr MJ, Schneider A, Hafer C, Haller H, Manns MP, Fliser D: Prometheus-a new extracorporeal system for the treatment of liver failure. J Hepatol 39:984-990, 2003
63. Krisper P, Tiran B, Fliser D, Haditsch B, Stadlbauer V, Otto R, Ernst T, Kretschmer U, Stauber RE, Haller H, Holzer H, Manns MP, Rifai K: Efficacy and safety of anticoagulation with heparin versus heparin plus epoprostenol in patients undergoing extracorporeal liver support with prometheus. Artif Organs 34:84-88, 2010
64. Bachli EB, Schuepbach RA, Maggiorini M, Stocker R, Müllhaupt B, Renner EL: Artificial liver support with the molecular adsorbent recirculating system: activation of coagulation and bleeding complications. Liver Int 27:475-484, 2000
65. Hui T, Rozga J, Demetriou AA: Bioartificial liver support. J Hepatobiliary Pancreat Surg 8:1-15, 2001
66. Sauer IM, Kardassis D, Zeillinger K, Pascher A, Gruenwald A, Pless G, Irgang M, Kraemer M, Puhl G, Frank J, Muller AR, Steinmuller T, Denner J, Neuhaus P, Gerlach JC: Clinical extracorporeal hybrid liver support-phase I study with primary porcine liver cells. Xenotransplantation 10:460-469, 2003
67. Sauer IM, Zeilinger K, Obermayer N, Pless G, Grunwald A, Pascher A, Mieder T, Roth S, Goetz M, Kardassis D, Mas A, Neuhaus P, Gerlach JC: Primary human liver cells as source for modular extracorporeal liver support-a preliminary report. Int J Artif Organs 25:1001-1005, 2002
68. Sussman NL, Gislason GT, Conlin CA, Kelly JH: The Hepatix extracorporeal liver assist device: initial clinical experience. Artif Organs 18:390-396, 1994
69. van de Kerkhove MP, Di Florio E, Scuderi V, Mancini A, Belli A, Bracco A, Dauri M, Tisone G, Di Nicuolo G, Amoroso P, Spadari A, Lombardi G, Hoekstra R, Calise F, Chamuleau RA: Phase I clinical trial with the AMC-bioartificial liver. Int J Artif Organs 25:950-959, 2002